For pandemic vaccine processing, single-use filter cartridges and membrane chromatography technologies could offer significant time- and cost-reduction advantages.
Niels Guldager
Advertisement
Articles by Niels Guldager
Advertisement
Latest Updated Articles
Pandemic Flu Preparedness: A Manufacturing PerspectivePublished: August 2nd 2007 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Report - Digital Transformation in Biopharma: The Gap Between Hype and Implementation
2
Reducing CAR-T Manufacturing Times and Cost: Q&A with Trenchant’s Jon Ellis
3
How Big Biopharma Investment in CGTs Will Redefine the Industry Pipeline
4
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
5
